Imerys S.A (0NPX) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Imerys S.A €11.63, price €22.32, upside -47.9%, quality 52 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Imerys S.A. engages in the supply of specialty minerals for various industries across Europe, the Middle East, Africa, Asia Pacific, and America.
Show more
Imerys S.A. engages in the supply of specialty minerals for various industries across Europe, the Middle East, Africa, Asia Pacific, and America. The company offers performance minerals, such as additives for plastics, paints and coatings, filtration and life sciences, ceramics, and building products; specialty minerals used as processing aids for extreme work conditions, including refractory, foundry, abrasives, and building chemistry; and graphite and carbon minerals for energy transition and mobile energy markets. It also provides minerals, such as andalusite, ball clay, bentonite, calcium carbonate, carbon black, chamotte, diatomite, feldspar, fused alumina, graphite, halloysite, kaolin, lithium, mica, moler, mullite, perlite, quartz, talc, zeolite, zirconia, and wollastonite. The company serves various markets, such as abrasives, advanced ceramics, animal care, batteries and fuel cells, building materials, ceramics, component manufacturing, cosmetics and personal care, crop production, food and beverage, health, pharmaceuticals and biotechnology, home care, infrastructure and utilities, investment casting, pulp and packaging, and rubber markets. The company was incorporated in 1880 and is headquartered in Paris, France. Imerys S.A. is a subsidiary of Belgian Securities BV.
Stock analysis
Imerys S.A (0NPX) currently trades at €22.32, while our model-based Fair Value estimate is €11.63, 47.9% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of €16.53 per share, and 4 of the 21 models we run sit above the €22.32 price.
Bear case: the Earnings-Based group reads lowest at €1.65, and 17 of the 21 models stay below the price. Evidence for this calculation is high.
Quality & growth
The Quality Score stands at 52/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Imerys S.A reported revenue of €3.8B in FY2020 versus €4.2B in FY2016, a compound −2.3%/yr. Reported net income was €30.1M in FY2020, compounding −43.4%/yr from FY2016.
Key figures
Market cap €3.4B · P/S ratio 1.01 · Net margin 0.8% · Return on equity −13.9% · Return on assets (EBIT) 3.6% · Operating margin 5.5% · Revenue (TTM) €3.3B · Revenue growth (YoY) −4.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).
What moves the price
The share trades about 17% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −48%, 0NPX screens richer than that median.
Fair Value models
Bear €11.63Fair Value €11.63Bull €11.63
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.38/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−12.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.0%
’16
’17
’18
’19
’20
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
11.8% (2016) → 3.6% (2020)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no share-count history
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Imerys S.A Fair Value". https://www.fairvalue-calculator.com/stock/0NPX
Frequently asked questions
Is Imerys S.A (0NPX) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of €11.63 versus a price of €22.32, about −48% upside (overvalued).
What is the fair value of 0NPX?
Our model-based fair value for Imerys S.A is €11.63 (as of Sep 24, 2026), built from audited fundamentals. The current price: €22.32.
What is the quality score of 0NPX?
Imerys S.A has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Imerys S.A (0NPX)?
Our model-based price target is the fair value of €11.63 (as of Sep 24, 2026) from 21 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Imerys S.A stock forecast for 2026?
Our models put fair value at €11.63, about −48% upside versus a price of €22.32 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Imerys S.A (0NPX)?
Imerys S.A reported trailing-twelve-month revenue of about €3.3B (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Imerys S.A (0NPX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Imerys S.A it is €11.63 per share (as of Sep 24, 2026), against a price of €22.32. It is the blended result of 21 valuation models (cash flow, earnings, asset, dividend).
Is Imerys S.A stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0NPX trades above its calculated fair value: price €22.32, fair value €11.63, a gap of about −48% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0NPX?
No. The price is what the market pays today (€22.32); the fair value is what the company's own numbers justify (€11.63). For Imerys S.A the two are €10.69 per share apart. That gap is exactly why we show both numbers side by side.
How much is Imerys S.A worth?
The market values Imerys S.A at about €3.4B (market capitalisation, as of Sep 24, 2026). Per share that is €22.32; our models calculate a fair value of €11.63 per share.
How far is 0NPX from its 52-week high?
Imerys S.A trades at €22.32, about 17% below its 52-week high of €26.99 and 17% above the low of €19.13 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of €11.63 is for.
Which stocks are comparable to Imerys S.A?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Imerys S.A stock attractive at the current price?
The data as of Sep 24, 2026: price €22.32, calculated fair value €11.63 (−48%), Quality Score 52/100, from 21 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0NPX calculated?
We run Imerys S.A through 21 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €11.63, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Imerys S.A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Imerys S.A (0NPX)?
The closing price on Oct 2, 2026 was €22.32. Our model-based fair value is €11.63, about −48% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Imerys S.A right now?
The price sits above even our optimistic bull case (€11.63). The favourable scenario is already priced in. Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Imerys S.A
How large is the market capitalisation of Imerys S.A (0NPX)?
The market capitalisation of Imerys S.A is €3.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Imerys S.A (0NPX)?
The price-to-sales ratio of Imerys S.A is 1.01 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Imerys S.A (0NPX)?
The net margin of Imerys S.A is 0.8% (fiscal year 2020). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Imerys S.A (0NPX)?
The return on equity (ROE) of Imerys S.A is −13.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Imerys S.A (0NPX)?
On an EBIT basis the return on assets of Imerys S.A is 3.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Imerys S.A (0NPX)?
The operating margin of Imerys S.A is 5.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Imerys S.A (0NPX)?
Revenue at Imerys S.A is growing −4.1% versus a year earlier (3y avg −4.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Imerys S.A (0NPX)?
Earnings per share at Imerys S.A are growing −34.7% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Continue in the live analysis
Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.
